Geode Capital Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
3,229,666
+159,548
| +5% | +$552K | ﹤0.01% | 2291 |
|
|
2025
Q1 | $8.05M | Buy |
3,070,118
+39,961
| +1% | +$105K | ﹤0.01% | 2423 |
|
|
2024
Q4 | $12.5M | Buy |
3,030,157
+297,887
| +11% | +$1.23M | ﹤0.01% | 2223 |
|
|
2024
Q3 | $19.3M | Buy |
2,732,270
+367,473
| +16% | +$2.6M | ﹤0.01% | 1994 |
|
|
2024
Q2 | $15.4M | Buy |
2,364,797
+148,004
| +7% | +$965K | ﹤0.01% | 2072 |
|
|
2024
Q1 | $18.4M | Buy |
2,216,793
+135,283
| +6% | +$1.12M | ﹤0.01% | 1970 |
|
|
2023
Q4 | $22.9M | Buy |
2,081,510
+110,522
| +6% | +$1.22M | ﹤0.01% | 1826 |
|
|
2023
Q3 | $16.6M | Buy |
1,970,988
+89,728
| +5% | +$755K | ﹤0.01% | 1948 |
|
|
2023
Q2 | $23.6M | Buy |
1,881,260
+126,730
| +7% | +$1.59M | ﹤0.01% | 1742 |
|
|
2023
Q1 | $28.9M | Buy |
1,754,530
+60,409
| +4% | +$995K | ﹤0.01% | 1560 |
|
|
2022
Q4 | $25.3M | Buy |
1,694,121
+143,146
| +9% | +$2.14M | ﹤0.01% | 1614 |
|
|
2022
Q3 | $34.7M | Buy |
1,550,975
+124,251
| +9% | +$2.78M | 0.01% | 1350 |
|
|
2022
Q2 | $23.9M | Buy |
1,426,724
+74,247
| +5% | +$1.24M | ﹤0.01% | 1642 |
|
|
2022
Q1 | $40.5M | Buy |
1,352,477
+47,461
| +4% | +$1.42M | 0.01% | 1399 |
|
|
2021
Q4 | $40.1M | Buy |
1,305,016
+239,756
| +23% | +$7.36M | ﹤0.01% | 1471 |
|
|
2021
Q3 | $33.6M | Buy |
1,065,260
+357,365
| +50% | +$11.3M | ﹤0.01% | 1605 |
|
|
2021
Q2 | $25.9M | Buy |
707,895
+103,962
| +17% | +$3.8M | ﹤0.01% | 1790 |
|
|
2021
Q1 | $20.9M | Buy |
603,933
+157,909
| +35% | +$5.46M | ﹤0.01% | 1853 |
|
|
2020
Q4 | $18.5M | Buy |
446,024
+9,042
| +2% | +$376K | ﹤0.01% | 1767 |
|
|
2020
Q3 | $18.6M | Buy |
+436,982
| New | +$18.6M | ﹤0.01% | 1590 |
|